Pyxis Oncology (PYXS) Insider Trading & Ownership $3.82 -0.34 (-8.17%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Pyxis Oncology (NASDAQ:PYXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.80%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$5.15 MNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$5.39 M Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PYXS Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Pyxis Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/27/2023Jitendra WadhaneCAOBuy2,500$1.87$4,675.00 9/27/2023Pamela Ann ConnealyCFOBuy6,426$1.85$11,888.10 9/25/2023Jitendra WadhaneCAOBuy5,000$1.77$8,850.00 9/25/2023Pamela Ann ConnealyCFOBuy12,000$1.67$20,040.00 9/22/2023Jitendra WadhaneCAOBuy2,500$1.74$4,350.00 9/22/2023Pamela Ann ConnealyCFOBuy5,000$1.74$8,700.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/18/2023Lara SullivanCEOSell8,541$2.10$17,936.10 9/13/2023Lara SullivanCEOSell3,000$2.27$6,810.00 9/11/2023Lara SullivanCEOSell20,000$2.27$45,400.00 3/17/2023Pfizer IncMajor ShareholderBuy1,811,594$2.76$4,999,999.44 4/21/2022Mark ChinDirectorSell1,745,761$3.05$5,324,571.05 12/8/2021Darren S ClineDirectorBuy10,000$9.39$93,900.00 (Data available from 1/1/2013 forward) PYXS Insider Trading Activity - Frequently Asked Questions Who is on Pyxis Oncology's Insider Roster? The list of insiders at Pyxis Oncology includes Darren S Cline, Jitendra Wadhane, Lara Sullivan, Mark Chin, Pamela Ann Connealy, and Pfizer Inc. Learn more on insiders at PYXS. What percentage of Pyxis Oncology stock is owned by insiders? 9.80% of Pyxis Oncology stock is owned by insiders. Learn more on PYXS's insider holdings. Which Pyxis Oncology insiders have been buying company stock? The following insiders have purchased PYXS shares in the last 24 months: Jitendra Wadhane ($17,875.00), Pamela Ann Connealy ($40,628.10), and Pfizer Inc ($4,999,999.44). How much insider buying is happening at Pyxis Oncology? Insiders have purchased a total of 1,845,020 PYXS shares in the last 24 months for a total of $5,058,502.54 bought. Which Pyxis Oncology insiders have been selling company stock? The following insider sold PYXS shares in the last 24 months: Lara Sullivan ($70,146.10). How much insider selling is happening at Pyxis Oncology? Insiders have sold a total of 31,541 Pyxis Oncology shares in the last 24 months for a total of $70,146.10 sold. Pyxis Oncology Key ExecutivesDr. Lara S. Sullivan M.D.MBA, CEO, President & DirectorMs. Pamela Yanchik Connealy M.B.A. (Age 62)CFO & COO Compensation: $709.7kDr. Ken Kobayashi FACP (Age 63)M.D., Chief Medical Officer Compensation: $314.08kMr. Jitendra Wadhane (Age 43)Chief Accounting Officer, Senior VP of Finance & Corporate Controller Dr. Balu N. Balasubramanian Ph.D.Interim Chief Technology OfficerDr. Jan Pinkas Ph.D.Chief Scientific OfficerDr. Charles T. Gombar Ph.D.Senior Vice President of Portfolio & Program Management More Insider Trading Tools from MarketBeat Related Companies MacroGenics Insider Transactions ADC Therapeutics Insider Transactions Rani Therapeutics Insider Transactions Adicet Bio Insider Transactions Shattuck Labs Insider Transactions Passage Bio Insider Transactions Bicycle Therapeutics Insider Transactions Collegium Pharmaceutical Insider Transactions Phibro Animal Health Insider Transactions ArriVent BioPharma Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:PYXS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
